WednesdayMay 21, 2025 1:30 pm

QualityStocksNewsBreaks – Trump Media & Technology Group Corp. (NASDAQ: DJT) Faces Scrutiny After AG Pam Bondi’s Stock Sale

Trump Media & Technology Group (NASDAQ: DJT) is under scrutiny following revelations that U.S. Attorney General Pam Bondi sold between $1 million and $5 million worth of the company's shares on April 2, 2025—the same day President Donald Trump announced significant new tariffs that led to a market downturn. Bondi's financial disclosure forms indicate the transactions occurred on that date, though it's unclear whether they were made before or after the market closed. The timing has raised questions about potential conflicts of interest, especially given Bondi's prior consultancy role with Digital World Acquisition Corp., the special purpose acquisition company that…

Continue Reading

WednesdayMay 21, 2025 10:30 am

ONAR Holding Corp. (ONAR): Building a Martech Powerhouse Through AI and Strategic Acquisitions

ONAR's acquisition-led growth operation is accelerating, with a major marketing tech acquisition set to double revenues at subsidiary Storia AI, data, and automation are at the core of ONAR’s efforts to help middle-market clients achieve measurable marketing performance Fiscal 2024 marked major operational progress, with asset growth, cost reduction, and increasing investor confidence through successful capital raises Marketing in the Age of AI and Data Marketing is undergoing a once-in-a-generation transformation, powered by artificial intelligence, real-time data, and next-generation automation. Today’s marketing systems aren’t static; they’re dynamic, adaptive, and personalized in real time. For growth-stage and middle-market businesses, this shift…

Continue Reading

WednesdayMay 21, 2025 9:45 am

Brera Holdings PLC (NASDAQ: BREA) Eyes Expansion as Sports Investing Gains Institutional Momentum

Sports investing is emerging as a recognized alternative asset class, attracting institutional capital. Media rights, digital expansion, and global fan engagement are driving up sports asset valuations, with the sector expected to surpass $700 billion in value by 2030. Brera focuses on sustainable football investment in growth-stage clubs rather than high-profile acquisitions; the company’s 2023 Nasdaq IPO was the first-ever listing of a multi-club ownership (“MCO”) group. A pending $2 billion IPO from Eagle Football Holdings could bring more visibility to the MCO model. As sports investing gains traction among institutional investors, Brera Holdings (NASDAQ: BREA), a global sports investment…

Continue Reading

WednesdayMay 21, 2025 9:10 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Expands Global Reach with Juve Stabia Playoff Match Streaming in U.S., Canada, UK

Brera Holdings (NASDAQ: BREA) announced that S.S. Juve Stabia’s Serie B semifinal playoff match against Cremonese will stream live and air free today in the U.S., Canada and UK via Destination Calcio TV, with full English commentary. The broadcast reflects Brera’s commitment to internationalizing its portfolio club's exposure as part of its multi-club ownership strategy. Executive Chairman Daniel McClory emphasized that expanding Juve Stabia’s global visibility during its Serie A playoff run showcases the company’s focus on fanbase growth and international media rights. The club, which finished 5th in Serie B, advanced to the semifinals after defeating Palermo 1-0. To…

Continue Reading

WednesdayMay 21, 2025 9:00 am

QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Present at Wall Street Conference on May 21

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced that Founder and CEO Dr. Jonathan Javitt will deliver a company update at the Wall Street Conference on May 21, 2025, in Palm Beach, Florida. NRx is one of six companies invited to present at the high-profile event, which is expected to draw more than 1,000 attendees representing over $1 trillion in investment capital. The presentation will highlight the company’s progress toward FDA approval of NRX-100, a preservative-free intravenous ketamine formulation, as well as its strategic acquisition plans for HOPE clinics focused on treating suicidal depression, PTSD, and related conditions. To…

Continue Reading

WednesdayMay 21, 2025 9:00 am

Adageis Offers Easy-to-Use AI-Driven Solution to Help Healthcare Providers Unlock High-Value Care, Maximize Revenue

Adageis delivers a user-friendly platform that helps providers identify high-value services while improving care quality. The company’s patented ProActive Care Platform leverages AI to shift providers from fee-for-service to value-based care models. The system integrates seamlessly with major EHR platforms to enhance operations without disrupting workflows. Adageis supports over 260,000 patient lives and expects that figure to more than double by the end of Q2 2025. The company is helping providers better understand insurance contract value and advocate for appropriate reimbursement. For healthcare practices navigating the shift toward value-based care, the complexity of insurance contracts, quality metrics, and data reporting…

Continue Reading

TuesdayMay 20, 2025 12:35 pm

FAVO Capital Inc. (FAVO) Delivering Funding Solutions in Private Credit Market, Poised for Significant Growth

Momentum suggests a positive trajectory in the private credit market in the coming year. FAVO Capital offers flexible capital solutions tailored to SMBs’ unique needs. The company’s approach exemplifies how private credit firms are leveraging technology to enhance their offerings. The private credit market is on the cusp of substantial expansion in 2025, driven by a resurgence in global mergers and acquisitions (“M&A”), the digitization of lending processes and the emergence of innovative financing solutions tailored for small and medium-sized businesses (“SMBs”) (https://ibn.fm/pDNA4). This confluence of factors is reshaping the financial landscape, as companies such as FAVO Capital (OTC: FAVO)…

Continue Reading

TuesdayMay 20, 2025 11:45 am

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) CEO Discusses Business Model, Competitive Advantage During GotStocks Podcast

CEO Dr. Richard Lu discussed SolarBank’s vertically integrated business model on a recent GotStocks podcast. SolarBank is an expanding developer, builder, operator, and owner of clean energy projects across North America, maintaining a $184 million portfolio of assets generating recurring revenue. The company’s flexible supply chain strategy helps mitigate any tariff risks while reducing costs. Going forward, a recently announced up to $100 million transaction with CIM Group is set to fund up to 97 MW of U.S. community solar projects. Disseminated on behalf of SolarBank Corporation Dr. Richard Lu, CEO of SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2),…

Continue Reading

TuesdayMay 20, 2025 10:00 am

Siyata Mobile Inc. (NASDAQ: SYTA) Is ‘One to Watch’ 

Siyata Mobile is gaining traction across North America with its purpose-built push-to-talk (PTT) devices and Uniden(R)-branded cellular signal boosters. Its SD7 handset offers a rugged, LTE-based replacement for traditional two-way radios in public safety and industrial sectors. Signal boosters enhance connectivity in vehicles, buildings, and remote zones, supporting mission-critical communications. Distribution wins with major U.S. carriers and public sector agencies highlight growing demand and deployment momentum. The company’s carrier-integrated model aligns with rising needs for scalable, reliable communication infrastructure. Siyata Mobile Inc. (NASDAQ: SYTA) is a technology company providing advanced communication solutions for frontline workers, emergency responders, and mobile workforces.…

Continue Reading

TuesdayMay 20, 2025 9:45 am

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Targets Global Sales Growth with Multilingual Digital Rollout

Medical technology company Intelligent Bio Solutions has launched Arabic, Italian, and Spanish websites to support expansion into key international markets. The move opens digital access to over 1.4 billion people across Latin America, the Middle East, and Southern Europe. The rollout aligns with increased demand for non-invasive workplace drug testing and compliance tools. INBS’s flagship fingerprint sweat-based drug screening system is currently used by over 450 clients in 24 countries. The company plans a U.S. market launch in 2025 as it continues to develop additional biosensor applications. Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered